Sars-cov-2 Genomic Sequence
- All
- News
-
5 Cases Of Covid Variant Behind Rise In US Cases Found In India
- Tuesday January 3, 2023
- India News | Press Trust of India
Five cases of COVID-19's XBB.1.5 variant, responsible for the rise in cases in the US, have been found in India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG).
- www.ndtv.com
-
Blow To India's Covid Genome Sequencing Efforts, 5 Labs Shut: Sources
- Thursday January 20, 2022
- India News | Reported by Parimal Kumar
Coronavirus: Delays in genome sequencing samples from Covid patients - to identify the strain of virus in each case - is due to a lack of funds for chemical reagents, top Health Ministry sources have told NDTV.
- www.ndtv.com
-
No Evidence On Omicron's Severity In India: Centre's Research Body
- Monday December 20, 2021
- India News | Press Trust of India
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant o
- www.ndtv.com
-
Genome Sequencing Panel "Closely Tracking" New Covid Variant: Official
- Friday November 26, 2021
- India News | Press Trust of India
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely tracking the new variant of Covid - B.1.1.529 - and its presence has not been detected in the country yet, officials said on Friday.
- www.ndtv.com
-
Delta Remains Main Variant Of Concern In India: Genome Sequencing Panel
- Thursday November 11, 2021
- India News | Press Trust of India
The Delta variant of COVID-19 continues to be the main variant of concern (VOC), while other variants of interest (VOI) or concern are now negligible in sequencing data from India, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said.
- www.ndtv.com
-
Eight Labs In Four Cities Part Of Consortium To Identify Covid Variants
- Friday June 11, 2021
- India News | Asian News International
Complementing national efforts led by Indian SARS-CoV-2 Genomic Consortia (INSACOG), a consortium of four city clusters - Bangalore, Hyderabad, Delhi and Pune - has been established to upscale the SARS-CoV-2 coronavirus genomic surveillance.
- www.ndtv.com
-
20,549 Fresh COVID-19 Cases In India, 25% Higher Than Yesterday
- Wednesday December 30, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Swati Bhasin
Amid global fears over the new mutant strains of coronavirus, detected in the United Kingdom and South Africa, India recorded 20,549 fresh infections in the last 24 hours, 25 per cent higher than yesterday. India's tally has surged to 1,02,44,852; 1.48 lakh deaths linked to the disease have been recorded so far. A consortium of 10 government labs h...
- www.ndtv.com
-
Scientists Working On SARS-CoV-2 Genomic Sequences To Fight COVID-19
- Monday September 14, 2020
- India News | ANI
A group of scientists in India is working on genomic sequences of SARS-CoV-2 around the world, including India, to identify genetic variability and potential molecular targets in virus and human to find the best possible answer to combat the COVID-19 virus.
- www.ndtv.com
-
5 Cases Of Covid Variant Behind Rise In US Cases Found In India
- Tuesday January 3, 2023
- India News | Press Trust of India
Five cases of COVID-19's XBB.1.5 variant, responsible for the rise in cases in the US, have been found in India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG).
- www.ndtv.com
-
Blow To India's Covid Genome Sequencing Efforts, 5 Labs Shut: Sources
- Thursday January 20, 2022
- India News | Reported by Parimal Kumar
Coronavirus: Delays in genome sequencing samples from Covid patients - to identify the strain of virus in each case - is due to a lack of funds for chemical reagents, top Health Ministry sources have told NDTV.
- www.ndtv.com
-
No Evidence On Omicron's Severity In India: Centre's Research Body
- Monday December 20, 2021
- India News | Press Trust of India
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant o
- www.ndtv.com
-
Genome Sequencing Panel "Closely Tracking" New Covid Variant: Official
- Friday November 26, 2021
- India News | Press Trust of India
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely tracking the new variant of Covid - B.1.1.529 - and its presence has not been detected in the country yet, officials said on Friday.
- www.ndtv.com
-
Delta Remains Main Variant Of Concern In India: Genome Sequencing Panel
- Thursday November 11, 2021
- India News | Press Trust of India
The Delta variant of COVID-19 continues to be the main variant of concern (VOC), while other variants of interest (VOI) or concern are now negligible in sequencing data from India, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said.
- www.ndtv.com
-
Eight Labs In Four Cities Part Of Consortium To Identify Covid Variants
- Friday June 11, 2021
- India News | Asian News International
Complementing national efforts led by Indian SARS-CoV-2 Genomic Consortia (INSACOG), a consortium of four city clusters - Bangalore, Hyderabad, Delhi and Pune - has been established to upscale the SARS-CoV-2 coronavirus genomic surveillance.
- www.ndtv.com
-
20,549 Fresh COVID-19 Cases In India, 25% Higher Than Yesterday
- Wednesday December 30, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Swati Bhasin
Amid global fears over the new mutant strains of coronavirus, detected in the United Kingdom and South Africa, India recorded 20,549 fresh infections in the last 24 hours, 25 per cent higher than yesterday. India's tally has surged to 1,02,44,852; 1.48 lakh deaths linked to the disease have been recorded so far. A consortium of 10 government labs h...
- www.ndtv.com
-
Scientists Working On SARS-CoV-2 Genomic Sequences To Fight COVID-19
- Monday September 14, 2020
- India News | ANI
A group of scientists in India is working on genomic sequences of SARS-CoV-2 around the world, including India, to identify genetic variability and potential molecular targets in virus and human to find the best possible answer to combat the COVID-19 virus.
- www.ndtv.com